Stay in touch
Prime news from our network.
#read
VivoSensMedical included in the Tech4Eva accelerator programme
VivoSensMedical is the only German company to be accepted into the Tech4Eva Accelerator. The initiative, which was launched in 2021 by the EPFL Innovation Park in Switzerland, supports FemTech companies worldwide. Out of 189 applications from 45 countries, 17 companies were selected for the programme.
13/05/2024
Over a period of six months, VivoSensMedical will participate in workshops and roadshows to present its medical device OvulaRing to investors and potential customers. OvulaRing is a certified biosensor that measures core body temperature and produces a cyclofertilogram (CFG) that maps cycle and fertility health.
Sebastian Alexander, CEO of VivoSensMedical, emphasises the importance of inclusion in the programme for the further development of the OvulaRing, which has already helped many women to become pregnant. Simone Theiss from the EPFL Innovation Park praised OvulaRing as the most advanced cycle tracker on the market and is looking forward to working with VivoSensMedical.
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.